Literature DB >> 32406202

Modeling Controlled Cortical Impact Injury in 3D Brain-Like Tissue Cultures.

Volha Liaudanskaya1, Joon Yong Chung2, Craig Mizzoni1, Nicolas Rouleau1, Alexander N Berk1, Limin Wu2, Julia A Turner1, Irene Georgakoudi1, Michael J Whalen2, Thomas J F Nieland1, David L Kaplan1.   

Abstract

Traumatic brain injury (TBI) survivors suffer long term from mental illness, neurodegeneration, and neuroinflammation. Studies of 3D tissue models have provided new insights into the pathobiology of many brain diseases. Here, a 3D in vitro contusion model is developed consisting of mouse cortical neurons grown on a silk scaffold embedded in collagen and used outcomes from an in vivo model for benchmarking. Molecular, cellular, and network events are characterized in response to controlled cortical impact (CCI). In this model, CCI induces degradation of neural network structure and function and release of glutamate, which are associated with the expression of programmed necrosis marker phosphorylated Mixed Lineage Kinase Domain Like Pseudokinase (pMLKL). Neurodegeneration is observed first in the directly impacted area and it subsequently spreads over time in 3D space. CCI reduces phosphorylated protein kinase B (pAKT) and Glycogen synthase kinase 3 beta (GSK3β) in neurons in vitro and in vivo, but discordant responses are observed in phosphprylated ribosomal S6 kinase (pS6) and phosphorylated Tau (pTau) expression. In summary, the 3D brain-like culture system mimicked many aspects of in vivo responses to CCI, providing evidence that the model can be used to study the molecular, cellular, and functional sequelae of TBI, opening up new possibilities for discovery of therapeutics.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  3D in vitro models; brain tissue; controlled cortical impact; neurodegeneration; tissue engineering; traumatic brain injuries

Mesh:

Year:  2020        PMID: 32406202      PMCID: PMC7395313          DOI: 10.1002/adhm.202000122

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  57 in total

Review 1.  Engineering three-dimensional microenvironments towards in vitro disease models of the central nervous system.

Authors:  Lara Yildirimer; Qiang Zhang; Shifeng Kuang; Chung-Wai James Cheung; Kyle Alexander Chu; Yong He; Mo Yang; Xin Zhao
Journal:  Biofabrication       Date:  2019-06-06       Impact factor: 9.954

Review 2.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

3.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

Authors:  Ha Nam Nguyen; Blake Byers; Branden Cord; Aleksandr Shcheglovitov; James Byrne; Prachi Gujar; Kehkooi Kee; Birgitt Schüle; Ricardo E Dolmetsch; William Langston; Theo D Palmer; Renee Reijo Pera
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

Review 4.  Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research.

Authors:  Andrew I R Maas; David K Menon; P David Adelson; Nada Andelic; Michael J Bell; Antonio Belli; Peter Bragge; Alexandra Brazinova; András Büki; Randall M Chesnut; Giuseppe Citerio; Mark Coburn; D Jamie Cooper; A Tamara Crowder; Endre Czeiter; Marek Czosnyka; Ramon Diaz-Arrastia; Jens P Dreier; Ann-Christine Duhaime; Ari Ercole; Thomas A van Essen; Valery L Feigin; Guoyi Gao; Joseph Giacino; Laura E Gonzalez-Lara; Russell L Gruen; Deepak Gupta; Jed A Hartings; Sean Hill; Ji-Yao Jiang; Naomi Ketharanathan; Erwin J O Kompanje; Linda Lanyon; Steven Laureys; Fiona Lecky; Harvey Levin; Hester F Lingsma; Marc Maegele; Marek Majdan; Geoffrey Manley; Jill Marsteller; Luciana Mascia; Charles McFadyen; Stefania Mondello; Virginia Newcombe; Aarno Palotie; Paul M Parizel; Wilco Peul; James Piercy; Suzanne Polinder; Louis Puybasset; Todd E Rasmussen; Rolf Rossaint; Peter Smielewski; Jeannette Söderberg; Simon J Stanworth; Murray B Stein; Nicole von Steinbüchel; William Stewart; Ewout W Steyerberg; Nino Stocchetti; Anneliese Synnot; Braden Te Ao; Olli Tenovuo; Alice Theadom; Dick Tibboel; Walter Videtta; Kevin K W Wang; W Huw Williams; Lindsay Wilson; Kristine Yaffe
Journal:  Lancet Neurol       Date:  2017-11-06       Impact factor: 44.182

5.  TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.

Authors:  Daniela Bermpohl; Zerong You; Eng H Lo; Hyung-Hwan Kim; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-04       Impact factor: 6.200

6.  A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes.

Authors:  E F Ellis; J S McKinney; K A Willoughby; S Liang; J T Povlishock
Journal:  J Neurotrauma       Date:  1995-06       Impact factor: 5.269

7.  Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice.

Authors:  Xiaoxia Zhu; Juyeon Park; Julianne Golinski; Jianhua Qiu; Jugta Khuman; Christopher C H Lee; Eng H Lo; Alexei Degterev; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-18       Impact factor: 6.200

8.  Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K/Akt/mTOR signaling pathway in rats with traumatic brain injury.

Authors:  Min Shen; Shan Wang; Xin Wen; Xin-Rui Han; Yong-Jian Wang; Xiu-Min Zhou; Man-He Zhang; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Biomed Pharmacother       Date:  2017-09-10       Impact factor: 6.529

9.  Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.

Authors:  Carl M Sellgren; Jessica Gracias; Bradley Watmuff; Jonathan D Biag; Jessica M Thanos; Paul B Whittredge; Ting Fu; Kathleen Worringer; Hannah E Brown; Jennifer Wang; Ajamete Kaykas; Rakesh Karmacharya; Carleton P Goold; Steven D Sheridan; Roy H Perlis
Journal:  Nat Neurosci       Date:  2019-02-04       Impact factor: 24.884

10.  Akt and mTOR mediate programmed necrosis in neurons.

Authors:  Q Liu; J Qiu; M Liang; J Golinski; K van Leyen; J E Jung; Z You; E H Lo; A Degterev; M J Whalen
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

View more
  5 in total

Review 1.  Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury.

Authors:  Chris G Dulla; Asla Pitkänen
Journal:  Neurotherapeutics       Date:  2021-09-30       Impact factor: 6.088

2.  Non-destructive monitoring of 3D cell cultures: new technologies and applications.

Authors:  Marilisa Cortesi; Emanuele Giordano
Journal:  PeerJ       Date:  2022-05-12       Impact factor: 3.061

3.  Bioengineered models of Parkinson's disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment.

Authors:  Nicholas J Fiore; Yosif M Ganat; Kapil Devkota; Rebecca Batorsky; Ming Lei; Kyongbum Lee; Lenore J Cowen; Gist Croft; Scott A Noggle; Thomas J F Nieland; David L Kaplan
Journal:  Cell Mol Life Sci       Date:  2022-01-19       Impact factor: 9.261

4.  Integrated functional neuronal network analysis of 3D silk-collagen scaffold-based mouse cortical culture.

Authors:  Yu-Ting L Dingle; Mattia Bonzanni; Volha Liaudanskaya; Thomas J F Nieland; David L Kaplan
Journal:  STAR Protoc       Date:  2021-01-25

5.  Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis.

Authors:  Limin Wu; Joon Yong Chung; Tian Cao; Gina Jin; William J Edmiston; Suzanne Hickman; Emily S Levy; Jordyn A Whalen; Eliza Sophie LaRovere Abrams; Alexei Degterev; Eng H Lo; Lorenzo Tozzi; David L Kaplan; Joseph El Khoury; Michael J Whalen
Journal:  Cell Death Dis       Date:  2021-11-09       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.